GlassScriptPhysician profile
Wendy O Walker
NPI 1922130830
$2,118.59
in general payments reported to CMS, 2019-2025
25 companies · $461 in 2025
The $461 reported for 2025 was more than what 95% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $414 · 2022: $171 · 2023: $677 · 2024: $395 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,533.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $485.90 | 2023-2024 | Xeomin |
| Medtronic, INC. | $375.05 | 2021-2025 | Interstim, Altaviva |
| Boston Scientific Corporation | $204.47 | 2021-2025 | Axonics, Solyx Sis System |
| Astellas Pharma US INC | $191.50 | 2021-2023 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $150.25 | 2023-2025 | Gemtesa |
| Galderma Laboratories, L.P. | $124.20 | 2021 | |
| Millicent US INC | $103.36 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Hologic Sales and Service, LLC | $84.33 | 2022-2024 | Aptima, Thinprep 2000 Processor |
| Axonics, INC. | $57.28 | 2023 | Axonics, Bulkamid |
| Angiodynamics, INC. | $46.32 | 2021-2022 | |
| Allergan, INC. | $38.40 | 2021 | |
| Abbvie INC. | $28.79 | 2022-2025 | |
| Davol INC. | $27.75 | 2024 | Phasix Mesh |
| Abc Home Medical Supply, INC. | $22.79 | 2024 | |
| Mission Pharmacal Company | $21.78 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18.19 | 2023 | Diamondback Peripheral |
| Cordis US Corp. | $17.46 | 2024 | S.M.A.R.T. Control |
| Convatec INC. | $17.24 | 2021 | |
| Pfizer INC. | $16.25 | 2022 | |
| Bard Peripheral Vascular, INC. | $16.06 | 2024 | Crosser Iq |
| Virtus Pharmaceuticals LLC | $16.04 | 2021 | |
| Innocoll Pharmaceuticals Limited | $15.46 | 2021 | |
| Hollister Incorporated | $14.43 | 2021 | |
| Urovant Sciences INC | $14.21 | 2022 | |
| Organon LLC | $11.08 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.